Sign in or register to see full information and data.

Studies / CAVD 527


Study information

Grant Affiliation:Haynes: B cell Lineage Envelope Design from RV144 Antibodies
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2015-10-20
Study Made Public:2017-11-22


Investigating monoclonal antibody neutralization breadth and potency after delayed and repetitive boosting with ALVAC-HIV and AIDSVAX B/E


CAVD 527 is a monoclonal antibody screening study evaluating broadly neutralizing antibodies in RV144 and RV305 subjects.


ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/E

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.